Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Paul Francis Dellaripa, M.D.

Co-Author

Back to Details
This page shows the publications co-authored by Paul Dellaripa and Jeffrey Sparks.
Paul Dellaripa
Connection Strength
2.590
Jeffrey Sparks
  1. Associations of the MUC5B Promoter Variant with Timing of Interstitial Lung Disease and Rheumatoid Arthritis Onset. Rheumatology (Oxford). 2022 Mar 15.
    View in: PubMed
    Score: 0.248
  2. Demographic, Lifestyle, and Serologic Risk Factors for Rheumatoid Arthritis-Associated Bronchiectasis: Role of RA-related Autoantibodies. J Rheumatol. 2022 Mar 15.
    View in: PubMed
    Score: 0.248
  3. Lifestyle and Clinical Risk Factors for Incident Rheumatoid Arthritis-associated Interstitial Lung Disease. J Rheumatol. 2021 05; 48(5):656-663.
    View in: PubMed
    Score: 0.226
  4. Pulmonary Adverse Events in Patients Receiving Low-Dose Methotrexate in the Randomized, Double-Blind, Placebo-Controlled Cardiovascular Inflammation Reduction Trial. Arthritis Rheumatol. 2020 12; 72(12):2065-2071.
    View in: PubMed
    Score: 0.225
  5. Rheumatoid arthritis-related lung disease detected on clinical chest computed tomography imaging: Prevalence, risk factors, and impact on mortality. Semin Arthritis Rheum. 2020 12; 50(6):1216-1225.
    View in: PubMed
    Score: 0.224
  6. Rheumatoid arthritis-associated interstitial lung disease: Current update on prevalence, risk factors, and pharmacologic treatment. Curr Treatm Opt Rheumatol. 2020 Dec; 6(4):337-353.
    View in: PubMed
    Score: 0.223
  7. Correction to: Association of rheumatoid arthritis-related autoantibodies with pulmonary function test abnormalities in a rheumatoid arthritis registry. Clin Rheumatol. 2020 04; 39(4):1371-1372.
    View in: PubMed
    Score: 0.217
  8. Association of rheumatoid arthritis-related autoantibodies with pulmonary function test abnormalities in a rheumatoid arthritis registry. Clin Rheumatol. 2019 12; 38(12):3401-3412.
    View in: PubMed
    Score: 0.207
  9. Rheumatoid Arthritis Disease Activity Predicting Incident Clinically Apparent Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Prospective Cohort Study. Arthritis Rheumatol. 2019 09; 71(9):1472-1482.
    View in: PubMed
    Score: 0.207
  10. Incidence and predictors of dyspnea on exertion in a prospective cohort of patients with rheumatoid arthritis. ACR Open Rheumatol. 2019 Mar; 1(1):4-15.
    View in: PubMed
    Score: 0.201
  11. Disclosure of Personalized Rheumatoid Arthritis Risk Using Genetics, Biomarkers, and Lifestyle Factors to Motivate Health Behavior Improvements: A Randomized Controlled Trial. Arthritis Care Res (Hoboken). 2018 06; 70(6):823-833.
    View in: PubMed
    Score: 0.189
  12. Screening for Preclinical Parenchymal Lung Disease in Rheumatoid Arthritis. Rheumatology (Oxford). 2021 Dec 07.
    View in: PubMed
    Score: 0.061
  13. Outcome measurement instrument selection for lung physiology in systemic sclerosis associated interstitial lung disease: A systematic review using the OMERACT filter 2.1 process. Semin Arthritis Rheum. 2021 12; 51(6):1331-1341.
    View in: PubMed
    Score: 0.060
  14. Adverse Effects of Low-Dose Methotrexate: A Randomized Trial. Ann Intern Med. 2020 03 17; 172(6):369-380.
    View in: PubMed
    Score: 0.054
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.